S&P 500
(-0.88%) 4 967.23 points
Dow Jones
(0.56%) 37 986 points
Nasdaq
(-2.05%) 15 282 points
Oil
(0.62%) $83.24
Gas
(0.17%) $1.760
Gold
(0.36%) $2 406.70
Silver
(1.29%) $28.75
Platinum
(-1.17%) $943.30
USD/EUR
(-0.14%) $0.938
USD/NOK
(-0.28%) $11.01
USD/GBP
(0.55%) $0.808
USD/RUB
(-0.96%) $93.00

Realtime updates for HELIUS MEDICAL [HSM.TO]

Exchange: TSX Industry: Medical Devices
Last Updated31 Dec 1970 @ 19:00

-1.71% $ 18.35

Live Chart Being Loaded With Signals

Commentary (31 Dec 1970 @ 19:00):

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma...

Stats
Today's Volume 930.00
Average Volume 738.00
Market Cap 0.00
EPS $-2.58 ( 2021-06-29 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.731
ATR14 $0 (0.00%)

HELIUS MEDICAL Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

HELIUS MEDICAL Financials

Annual 2020
Revenue: $661 000
Gross Profit: $273 000 (41.30 %)
EPS: $-11.80
Q2 2021
Revenue: $71 000.00
Gross Profit: $4 000.00 (5.63 %)
EPS: $-2.58
Q1 2021
Revenue: $84 000.00
Gross Profit: $69 000.00 (82.14 %)
EPS: $-1.650
Q4 2020
Revenue: $191 000
Gross Profit: $-10 000.00 (-5.24 %)
EPS: $-1.770

Financial Reports:

No articles found.

HELIUS MEDICAL

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator (PoNS), a medical device in Canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. The company is headquartered in Newtown, Pennsylvania.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators